Hepatic Metabolic Changes in Response to Glucagon Infusion

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

June 12, 2019

Study Completion Date

June 12, 2019

Conditions
Non-Alcoholic Fatty Liver DiseaseTotal PancreatectomyDiabetes Mellitus
Interventions
DRUG

Glucagon

Glucagon (4 ng/kg/min)

DRUG

Saline

Placebo

Trial Locations (1)

2900

Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

lead

Steno Diabetes Center Copenhagen

OTHER

NCT03526445 - Hepatic Metabolic Changes in Response to Glucagon Infusion | Biotech Hunter | Biotech Hunter